Summary
Chlorambucil, phenyl acetic mustard, melphalan and mitoclomine are aromatic nitrogen mustard derivatives. These drugs show a fairly wide range of chemical reactivity and lipophilicity. In the series presently investigated, the more hydrophilic compounds (melphalan and phenyl acetic mustard) are the more toxic to mice and also the more active against Moloney sarcoma implanted IP in mice. No clear relation could be shown between the alkylating activity and the biological efficiency. All the compounds induce changes in DNA synthesis with differences between the timing of alterations and recovery. Nevertheless, return to pretreatment levels of thymidine incorporation is more rapid in the bone marrow and intestinal mucosa following administration of the drugs, than in tumor cells. The14C-ethyl labeled compounds was used to investigate the part of the carrying structure in their disposition in mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberts DS, Chang SY, Chen SHG (1979) Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Cancer Treat Rev [Suppl] 6:9
Bardos TJ, Chmielewicz ZF, Hebborn P (1969) Structure activity relationships of alkylating agents in cancer chemotherapy. Ann NY Acad Sci 163:1006
Bergel F, Stock JA (1954) Cytoactive amino-acid and peptides derivatives. I. Substituted phenylalanines. J Chem Soc 5:2409
Burton K (1956) Study of the conditions of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315
Chang SY, Alberts DS, Melnick LR (1978) High-pressure liquid chromatographic analysis of melphalan in plasma. J Pharm Sci 67:679
Cohn P (1957) The distribution of radioactivity in tissues of the rat following the administration of a nitrogen mustard derivative: (p-di-(2 chloroethyl) amino-DL-phenyl14C alanine). Br J Cancer 11:258
Colvin M, Brundrett RB, Kan MNN (1976) Alkylating properties of phosphoramide mustard. Cancer Res 36:1121
Connors TA, Farmer PB, Foster AB (1973) Metabolism of aniline mustard (N,N-di-(2-chloroethyl) aniline). Biochem Pharmacol 22:1971
Currey HLF (1970) Immunosuppressive drugs in rheumatoid arthritis. In: Modern trends in rheumatology. Butterworths, London, p 174
Elson LA, Galton DAG, Till M (1958) The action of chlorambucil (C.B. 1348) and busulphan (myleran) on the hematopoietic organs of the rat. Br J Haematol 4:355
Everett JL, Roberts JJ, Ross WCJ (1953) Aryl-2-halogenoal-kylamines. XII. Some carboxylic derivatives ofN,N-di-2-chloroethylaniline. J Chem Soc 2386
Finney DJ (1974) Statistical methods in biological assay. Cloriffinand, London
Fox M, Rees RWM, Bennett DHJ, Henry L (1971) Investigations into the lymphopoenic and immunosuppressive properties of the antitumour agent, mitoclomine. Lymphology 4:35
Furner RL, Brown RK, Duncan G (1977) Pharmacokinetics of the absorption, distribution and elimination of melphalan in the dog. Cancer Treat Rep 61:1637
Galton DAG, Israels LG, Nabarro JDN, Till M (1965) Clinical trials of p.di (2-chloroethylamine)-phenylbutyric acid (CB 1348) in malignant lymphoma. Br Med J II:1172
Godenèche D, Madelmont JC, Sauvezie B, Billaud A (1975) Etude de la cinétique d'absorption, de distribution et d'élimination de l'acideN,N-dichloro-2-ethyl-p-amino-phenyl-4, butyrique (chloraminophène) marqué au14C chez le rat. Biochem Pharmacol 24:1303
Godenèche D, Madelmont JC, Moreau MF, Plagne R (1978) Disposition of a new alkylating agent14C-mitoclomine (N,N-bis-(2-chloroethyl)4-amino-2-methyl-1-methoxy naphtalene). Xenobiotica 8:597
Hansch C, Smith N, Engler, Wood H (1972) Quantitative structure-activity relationships of antineoplastic drugs: nitrosoureas and triazenoimidazoles. Cancer Chemother Rep 56:443
Kahn AH, Ross WCJ (1969/70) Tumour-growth inhibitory nitrophenyl aziridines and related compounds: structure-activity relationships. Chem Biol Interact 1:27
Kahn MF, Bedoiseau M, Six B, Le Goff P, De Sèze S (1971) Le chlorambucil dans la polyarthrite rhumatoïde. Rev Rhum Mol Osteoartic 38:741
Longeval E, Gangji D, Stryckmans P, Kenis Y (1975) Phase I–II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemia. Cancer Chemother Rep [I] 59:1173
McLean A, Newell D, Baker G (1976) The metabolism of chlorambucil. Biochem Pharmacol 25:2331
McLean A, Woods RL, Catovsky D, Farmer P (1979) Pharmacokinetics and metabolism of chlorambucil in patients with malignant discase. Cancer Treat Rev [Suppl] 6:33
Madelmont JC, Moreau MF, Godenèche D (1978) Synthèse et marquage au14C du N,N-dichloro-2-éthyl-amino-4-méthyl-2-méthoxy-1-naphtalène ou mitoclomine. J Lab Comp 14:281
Marrian DH, Maxwell DR (1956) Tracer studies of potential radiosensitizing agents, tetrasodium 2-14C-methyl-1: 4-naphthohydroquinone diphosphate. Br J Cancer 10:575
Mathé G, Kenis Y (1975) La chimiothérapie des cancers. Expansion Scientifique Française, Paris
Mitoma C, Onodera T, Takegoshi T, Thomas DW (1977) Metabolic disposition of chlorambucil in rats. Xenobiotica 7:205
Moreau J, Madelmont JC (1974) Synthèse de l'acideN,N-di-(chloro-2-ethyl)-p-amino-phenyl-4-butyrique (chloraminophène) marqué par14C. J Lab Comp 10:271
Newell DR, Hart LI, Harrap KR (1979) Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high performance liquid chromatography. J Chromatogr 164:114
Nicolas C, Godenèche D (1978) Synthése et marquage au14C de lap-bis-(chloro-2-ethyl)-amino-L phenylalanine ou melphalan. J Lab Comp 14:205
Panthananickal A, Hansch C, Leo A, Quinn FR (1978) Structure-activity relationships in antitumour aniline mustards. J Med Chem 21:16
Penniston JT, Beckett L, Bentley DL, Hansch C (1969) Passive permeation of organic compounds through biological tissue: a non steady-state theory. Mol Pharmacol 5:333
Ponti GB, Eridani S, Astaldi G, Giangrande A (1969) In vitro incorporation of3H-thymidine,3H-leucine, and3H-melphalan by plastocytoma plasma cells. Cell Tissue Kinet 2:157
Ross WCJ (1962) Biological alkylating agents. Butterworths, London and Washington
Ross WCJ (1974) Rational design of alkylating agents. In: Sartorelli AC, Johns DG (eds) Antineoplastic and Immuno-suppressive Agents. Handb Exp Pharmacol XXXVIII:33
Schmidt G, Tannhauser SJ (1945) A method for the determination of deoxydribonucleic acid, ribonucleic acid and phosphoproteins in animal tissues. J Biol Chem 161:83
Ullberg S, Hammarstrom L, Appelgren LE (1971) Autoradiography in pharmacology. In: The International encylcopaedia of pharmacology. Pergamon Press, Oxford New York, p 221
Vitisca DT, Toal JN, Rabinovitz M (1978) Amino acid-conferred protection against Melphalan — characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells. Biochem Pharmacol 27:2865
Wannemacker RW, Banks WL, Wunner WH (1965) Use of a single extract to determine cellular protein and nucleic acid concentrations and rate of amino acid incorporation. Anal Biochem 11:320
Wheeler GP, Bowden BJ, Grimsley JA, Lloyd HH (1974) Interrelationships of some chemical, physicochemical and biological activities of several 1-(2-halo ethyl)-1-nitrosoureas. Cancer Res 34:194
Wodinsky F, Merker PC, Venditti JM (1977) Responsiveness to chemotherapy of mice with L1210 lymphoid leukemia implanted in various anatomic sites. J Natl Cancer Inst 59:405
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Godenèche, D., Madelmont, J.C., Moreau, M.F. et al. Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. Cancer Chemother. Pharmacol. 5, 1–9 (1980). https://doi.org/10.1007/BF00578555
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00578555